Overall rank by patents
#8,483
of 50,000 tracked assignees
USPTO PatentsView assignee record - 38 granted patents across 55 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION).
The verdict
According to USPTO PatentsView, Suzhou ranks #8,483 of 50,000 tracked US assignees by granted-patent volume, with 38 patents across 55 technology areas.
USPTO PatentsView assignee plate
Corpus R8483 · Foreign Corporation #8,483 · 38 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Sapience Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Hutchinson · near
58 score
Atlassian PTY · near
58 score
Suzhou Institute OF… · this assignee
58 score
W r Grace & -conn · near
58 score
Poly-med · near
58 score
3D Lighting Innovati… · lowest
7 score
What this shows Suzhou Institute OF Nano-tech AND Nano-bionics (sinano) , Chinese Academy OF Sciences stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-WIDE, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-SURGE, BOOK-FULL. Volume places it #8,483 of 50,000; Innovation Score 58.3/100 sits in the top 5% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Sapience Therapeutics, Inc. (±0 grants).
Suzhou Institute OF Nano-tech AND Nano-bionics (sinano) , Chinese Academy OF Sciences has been granted 38 US utility patents between 2017 and 2025, placing Suzhou Institute OF Nano-tech AND Nano-bionics (sinano) , Chinese Academy OF Sciences at #8,483 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.4 claims per patent with primary concentration in Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION). As a Foreign Corporation, Suzhou Institute OF Nano-tech AND Nano-bionics (sinano) , Chinese Academy OF Sciences is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Suzhou sits between SBI Pharmaceuticals Co., Ltd. (38 patents, rank #8,472) and Secureauth Corporation (38 patents, rank #8,480) - the closest US assignees by grant volume. The composite Innovation Score of 58.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 27 grants, compared with 3 in the 2015–2019 window, a +800% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Suzhou Institute OF Nano-tech AND Nano-bionics (sinano) , Chinese Academy OF Sciences's 14.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 55 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SBI Pharmaceuticals Co., Ltd.
38 patents
SDCmaterials, Inc.
38 patents
SDL Inc.
38 patents
SHENZHEN HITHIUM ENERGY STORAGE TECHNOLOGY CO., LTD
38 patents
SYNC-RX LTD.
38 patents
Sapience Therapeutics, Inc.
38 patents
Sarcos Corp.
38 patents
SecureAuth Corporation
38 patents
SUZHOU INSTITUTE OF NANO-TECH AND NANO-BIONICS (SINANO) , CHINESE ACADEMY OF SCIENCES
38 patents
What this shows Suzhou holds 38 patents at rank #8,476, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,476 in granted patent volume.
Other assignees with the most granted patents in Suzhou's primary technology class.
Two PlainPatent-derived peer sets for Suzhou, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (58 here).
Suzhou's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 2.6% |
| 2018 | 1 | 2.6% |
| 2019 | 1 | 2.6% |
| 2020 | 7 | 18.4% |
| 2021 | 2 | 5.3% |
| 2022 | 2 | 5.3% |
| 2023 | 6 | 15.8% |
| 2024 | 10 | 26.3% |
| 2025partial year | 8 | 21.1% |
Top 15 of 55 technology areas
Overall rank by patents
#8,483
of 50,000 tracked assignees
58.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.